Perhaps one of the more surprising AI value plays is Google parent Alphabet ( GOOGL -0.01%) ( GOOG 0.06%). Alphabet has ...

Discussing how the market initially reacted, Cramer explained that when the panel of federal judges declared the majority of ...

Don't be scared about running out of money, be prepared. This financial professional explains how you can help take control ...

Have you ever read a headline that made you want to throw your phone across the room? Not out of anger, but frustration for your own bad investing decisions? You know the headlines I mean. “NVIDIA up ...

What are the best tech-focused ETFs for investors right now? Seeking Alpha analysts offer their picks. Read more here.

Salesforce lags despite solid profits, but AI traction, M&A moves, and low valuation offer upside. See why CRM stock is ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) announced favorable Phase 3 trial results for itepekimab and entered a significant licensing agreement with Telesis Bio, enhancing its R&D capabilities.